Back

TAVI with atrial fibrillation: which antithrombotic regimen?

29 August 2017 (11:36 - 11:54)
Organised by:
Congress Presentation Part of: Tough decisions around TAVI Aortic valve surgery ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Gilles Montalescot

Sorbonne University, Paris (France)

4 More presentations in this session

Presentation thumbnail
When is TAVI futile?
Professor C. Otto (Seattle, US)
Slides Video
Presentation thumbnail
Increased gradient post TAVI: what to accept during follow-up
Professor N. Ajmone Marsan (Leiden, NL)
Slides Video
Presentation thumbnail
Asymptomatic leaflet thrombosis after TAVI: what to do?
Professor F. Neumann (Bad Krozingen, DE)
Slides Video
Presentation thumbnail
Coronary artery disease in TAVI, if and when to treat?
Doctor K. Hayashida (Osaka, JP)
Slides Video

Access the full session

Session thumbnail
Tough decisions around TAVI

The Event

Event poster

ESC Congress 2017

29 August 2017 11:36 CET
You may be interested in
thumbnail
Congress Presentation
A patient with atrial fibrillation and severe aortic stenosis undergoing TAVI: how I would treat.
26 August 2022
thumbnail
Congress Presentation
Evaluation of new-onset atrial fibrillation using continuous patch monitor in patients undergoing transcatheter aortic valve replacement
28 August 2020
thumbnail
Congress Presentation
Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience
2 September 2019
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources